SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001485003-18-000098
Filing Date
2018-06-14
Accepted
2018-06-14 20:15:35
Documents
2
Period of Report
2018-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152902171899785.html 4  
1 FORM 4 wf-form4_152902171899785.xml 4 4160
2 DANIEL LYNCH POA ex-24.htm EX-24 4323
  Complete submission text file 0001485003-18-000098.txt   9832
Mailing Address
Business Address
LYNCH DANIEL (Reporting) CIK: 0001177082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 18900525

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations